Cited by 230Cannabis and Cannabinoid ResearchPain Mechanisms and TreatmentsPain Management and Treatment

The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.

Changes in spinal and supraspinal endocannabinoid levels in neuropathic rats

Petrosino, Stefania, Palazzo, Enza, de Novellis, Vito, Bisogno, Tiziana, Rossi, Francesco, Maione, Sabatino, Di Marzo, Vincenzo·2007·Neuropharmacology

DOI 10.1016/j.neuropharm.2006.08.011

Open this paper in CoChat — free account

Abstract

Recent studies have shown that activation of the cannabinoid CB(1) receptor by synthetic agonists, and pharmacological elevation of endocannabinoid levels, suppress hyperalgesia and allodynia in animal models of neuropathic pain. However, the concentrations of endocannabinoids in the nervous tissues involved in pain transmission during neuropathic pain have never been measured. Here we have determined the levels of anandamide and 2-arachidonoylglycerol (2-AG), as well as of the analgesic anandamide congener, palmitoylethanolamide (PEA), in three brain areas involved in nociception, i.e. the dorsal raphe (DR), periaqueductal grey (PAG) and rostral ventral medulla (RVM), as well as in the spinal cord (SC), following chronic constriction injury (CCI) of the sciatic nerve in the rat, in comparison with sham-operated rats. After 3 days from CCI, anandamide or 2-AG levels were significantly enhanced only in the SC or PAG, respectively. After 7 days from CCI, when thermal hyperalgesia and mechanical allodynia are maximal, a strong (1.3-3-fold) increase of both anandamide and 2-AG levels was observed in the PAG, RVM and SC. At this time point, anandamide, but not 2-AG, levels were also enhanced in the DR. PEA levels were significantly decreased in the SC after 3 days, and in the DR and RVM after 7 days from CCI. These data indicate that anandamide and 2-AG, operating at both spinal and supra-spinal levels, are up-regulated during CCI of the sciatic nerve, possibly to inhibit pain. Yet to be developed substances that inhibit both endocannabinoid and PEA inactivation might be useful for the treatment of neuropathic pain.

Integrity signals

Registry

Crossref · 10.1016/j.neuropharm.2006.08.011

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man
Bennett, G. J., & Xie, Y.-K. (1988) · Pain · doi:10.1016/0304-3959(88)90209-6 · Cited by 5,376
The endogenous cannabinoid system controls extinction of aversive memories
Marsicano, G., Wotjak, C. T., Azad, S. C., Bisogno, T., Rammes, G., Cascio, M. G., Hermann, H., Tang, J., Hofmann, C., Zieglgänsberger, W., et al. (2002) · Nature · doi:10.1038/nature00839 · Cited by 1,728
Self-citation
Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide
Bisogno, T., Hanuš, L., PETROCELLIS, L. D., Tchilibon, S., Ponde, D. E., Brandi, I., Moriello, A. S., Davis, J. B., Mechoulam, R., & Marzo, V. D. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704327 · Cited by 1,315
Self-citation
Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1‐like immunoreactivity, in the central nervous system of the rat and human
Mezey, É., Tóth, Z. E., Cortright, D. N., Arzubi, M. K., Krause, J. E., Elde, R., Guo, A., Blumberg, P. M., & Szallasi, A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3655 · Cited by 850
An endocannabinoid mechanism for stress-induced analgesia
Hohmann, A. G., Suplita, R. L., Bolton, N. M., Neely, M. H., Fegley, D., Mangieri, R., Krey, J. F., Michael Walker, J., Holmes, P. V., Crystal, J. D., et al. (2005) · Nature · doi:10.1038/nature03658 · Cited by 778
Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis
Rog, D. J., Nurmikko, T. J., Friede, T., & Young, C. A. (2005) · Neurology · doi:10.1212/01.wnl.0000176753.45410.8b · Cited by 679
Pain modulation by release of the endogenous cannabinoid anandamide
Walker, J. M., Huang, S. M., Strangman, N. M., Tsou, K., & Sañudo-Peña, M. C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.21.12198 · Cited by 486
Descending modulation in persistent pain: an update
Ren, K., & Dubner, R. A. (2002) · Pain · doi:10.1016/s0304-3959(02)00368-8 · Cited by 427
Induction of CB2 receptor expression in the rat spinal cord of neuropathic but not inflammatory chronic pain models
Zhang, J., Hoffert, C., Vu, H. K., Groblewski, T., Ahmad, S., & O'Donnell, D. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02704.x · Cited by 419

Flagged first, then by citations

Show all 46 references

Research works printed but not linked: 2

Costa, B., Colleoni, M., Trovato, A.E., Conti, S., Pomelli, F., Franke, C., 2005. Anandamide uptake and hydrolysis as targets for the treatment of neuropathic pain: effect of AM404 and URB597 in rats with chronic constriction injury of the sciatic nerve. XV Symposium on the Cannabinoids, Clearwater Beach, FL, 24–29 June 2005, p. 33.
Costa, B., Comelli, F., Colleoni, M., Giagnoni, G., 2006. Effect of CB1/TRPV1 agonist, arvanil, in acute inflammation and in persistent inflammatory and neuropathic pain. XVI Symposium on the Cannabinoids, Tihany, Hungary, 24–29 June 2006, p. 38.

Sorted by citations

Items 101–200 of 230

N-Arachidonyl Maleimide Potentiates the Pharmacological and Biochemical Effects of the Endocannabinoid 2-Arachidonylglycerol through Inhibition of Monoacylglycerol Lipase
Burston, J. J., Sim‐Selley, L. J., Harloe, J. P., Mahadevan, A., Razdan, R. K., Selley, D. E., & Wiley, J. L. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.141382 · Cited by 44
WWL70 protects against chronic constriction injury-induced neuropathic pain in mice by cannabinoid receptor-independent mechanisms
Wen, J., Jones, M., Tanaka, M., Selvaraj, P., Symes, A. J., Cox, B. M., & Zhang, Y. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-017-1045-9 · Cited by 43
AM404, an anandamide transport inhibitor, reduces plasma extravasation in a model of neuropathic pain in rat: role for cannabinoid receptors
La Rana, G., Russo, R., D'Agostino, G., Sasso, O., Raso, G. M., Iacono, A., Meli, R., Piomelli, D., & Calignano, A. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.10.021 · Cited by 42
Allosteric Cannabinoid Receptor 1 (CB1) Ligands Reduce Ocular Pain and Inflammation
Thapa, D., Cairns, E. A., Szczesniak, A.-M., Kulkarni, P. M., Straiker, A. J., Thakur, G. A., & Kelly, M. E. M. (2020) · Molecules · doi:10.3390/molecules25020417 · Cited by 42
Opioid-Induced Hyperalgesia Is Associated with Dysregulation of Circadian Rhythm and Adaptive Immune Pathways in the Mouse Trigeminal Ganglia and Nucleus Accumbens
Zhang, P., Moye, L. S., Southey, B. R., Dripps, I. J., Sweedler, J. V., Pradhan, A. A. A., & Rodriguez‐Zas, S. L. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01650-5 · Cited by 39
Misdiagnosed Chronic Pelvic Pain: Pudendal Neuralgia Responding to a Novel Use of Palmitoylethanolamide: Table 1
Calabrò, R. S., Gervasi, G., Marino, S., Mondo, P. N., & Bramanti, P. (2010) · Pain Medicine · doi:10.1111/j.1526-4637.2010.00823.x · Cited by 39
Palmitoylethanolamide modulates pentobarbital-evoked hypnotic effect in mice
Sasso, O., Rana, G. L., Vitiello, S., Russo, R., D’Agostino, G., Iacono, A., Russo, E., Citraro, R., Cuzzocrea, S., Piazza, P. V., et al. (2009) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2009.09.003 · Cited by 39
Palmitoylethanolamide, a neutraceutical, in nerve compression syndromes: efficacy and safety in sciatic pain and carpal tunnel syndrome
Hesselink, J. M. K., & Kopsky, D. J. (2015) · Journal of Pain Research · doi:10.2147/jpr.s93106 · Cited by 38
Enhancement of the hypotensive effects of intrathecally injected endocannabinoids by the entourage compound palmitoylethanolamide
García, M. D. C., Adler‐Graschinsky, E., & Celuch, S. M. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.03.021 · Cited by 38
Central functional response to the novel peptide cannabinoid, hemopressin
Dodd, G. T., Worth, A. A., Hodkinson, D. J., Srivastava, R. K., Lutz, B., Williams, S. R., & Luckman, S. M. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.03.007 · Cited by 38
Feedback mechanisms in the regulation of intracellular calcium ([Ca2+]i) in the peripheral nociceptive system: Role of TRPV-1 and pain related receptors
Hagenacker, T., Ledwig, D., & Büsselberg, D. (2007) · Cell Calcium · doi:10.1016/j.ceca.2007.05.019 · Cited by 40
Non-psychotropic analgesic drugs from the endocannabinoid system: “Magic bullet” or “multiple-target” strategies?
Starowicz, K., & Marzo, V. D. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.01.075 · Cited by 39
Effects of COX-2 inhibition on spinal nociception: the role of endocannabinoids.
Staniaszek, L., Norris, L., Kendall, D., Barrett, D., & Chapman, V (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00703.x · Cited by 36
Antihyperalgesic Activities of Endocannabinoids in a Mouse Model of Antiretroviral-Induced Neuropathic Pain
Munawar, N., Oriowo, M. A., & Masocha, W. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00136 · Cited by 36
Centrally mediated antinociceptive effects of cannabinoid receptor ligands in rat models of nociception
Hama, A. T., & Sagen, J. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.09.004 · Cited by 36
The 17-β-oestradiol inhibits osteoclast activity by increasing the cannabinoid CB2 receptor expression
Rossi, F., Bellini, G., Luongo, L., Mancusi, S., Torella, M., Tortora, C., Manzo, I., Guida, F., Nobili, B., de Novellis, V., et al. (2012) · Pharmacological Research · doi:10.1016/j.phrs.2012.10.017 · Cited by 35
Self-citation
NSAIDs: eNdocannabinoid stimulating anti-inflammatory drugs?
Fowler, C. J. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.05.003 · Cited by 33
Endocannabinoid modulation by FAAH and monoacylglycerol lipase within the analgesic circuitry of the periaqueductal grey
Lau, B. K., Drew, G. M., Mitchell, V. A., & Vaughan, C. W. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12839 · Cited by 35
Chronic constriction injury reduces cannabinoid receptor 1 activity in the rostral anterior cingulate cortex of mice
Hoot, M. R., Sim‐Selley, L. J., Poklis, J. L., Abdullah, R. A., Scoggins, K. L., Selley, D. E., & Dewey, W. L. (2010) · Brain Research · doi:10.1016/j.brainres.2010.03.105 · Cited by 34
Cross-sensitization and cross-tolerance between exogenous cannabinoid antinociception and endocannabinoid-mediated stress-induced analgesia
Suplita, R. L., Eisenstein, S. A., Neely, M. H., Moise, A. M., & Hohmann, A. G. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.07.006 · Cited by 33
Endocannabinoid and Prostanoid Crosstalk in Pain
Buisseret, B., Alhouayek, M., Guillemot‐Legris, O., & Muccioli, G. G. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2019.04.009 · Cited by 30
Peripheral deficiency and antiallodynic effects of 2-arachidonoyl glycerol in a mouse model of paclitaxel-induced neuropathic pain
Thomas, A., Okine, B. N., Finn, D. P., & Masocha, W. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110456 · Cited by 32
Significance of Omega-3 Fatty Acids in the Prophylaxis and Treatment after Spinal Cord Injury in Rodent Models
Wojdasiewicz, P., Poniatowski, Ł. A., Turczyn, P., Frasuńska, J., Paradowska‐Gorycka, A., & Tarnacka, B. (2020) · Mediators of Inflammation · doi:10.1155/2020/3164260 · Cited by 35
Endocannabinoid regulation of spinal nociceptive processing in a model of neuropathic pain
Sagar, D. R., Jhaveri, M. D., Richardson, D. S., Gray, R., de Lago, E., Fernández‐Ruíz, J., Barrett, D. A., Kendall, D. A., & Chapman, V. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07162.x · Cited by 30
Effect of palmitoylethanolamide on inflammatory and neuropathic pain in rats
Seol, T., Lee, W., Park, S., Kim, K. N., Kim, T. Y., Oh, Y. N., & Jun, J. H. (2017) · Korean Journal of Anesthesiology · doi:10.4097/kjae.2017.70.5.561 · Cited by 28
The endocannabinoid system in migraine: from bench to pharmacy and back
Tassorelli, C., Greco, R., & Silberstein, S. D. (2019) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000688 · Cited by 32
Targeting the endogenous cannabinoid system to treat neuropathic pain
Lau, B. K., & Vaughan, C. W. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00028 · Cited by 27
Alterations in Anandamide Synthesis and Degradation during Osteoarthritis Progression in an Animal Model
Bryk, M., Chwastek, J., Kostrzewa, M., Mlost, J., Pędracka, A., & Starowicz, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197381 · Cited by 27
Sex Differences in a Rat Model of Peripheral Neuropathic Pain and Associated Levels of Endogenous Cannabinoid Ligands
Boullon, L., Finn, D. P., & Llorente‐Berzal, A. (2021) · Frontiers in Pain Research · doi:10.3389/fpain.2021.673638 · Cited by 28
Combined non-psychoactive Cannabis components cannabidiol and β-caryophyllene reduce chronic pain via CB1 interaction in a rat spinal cord injury model
Eeswara, A., Pacheco-Spiewak, A., Jergová, S., & Sagen, J. (2023) · PLoS ONE · doi:10.1371/journal.pone.0282920 · Cited by 26
Cannabinoid subtype-2 receptors modulate the antihyperalgesic effect of WIN 55,212-2 in rats with neuropathic spinal cord injury pain
Ahmed, M. M., Rajpal, S., Sweeney, C., Gerovac, T. A., Allcock, B., McChesney, S. L., Patel, A. U., Tilghman, J. I., Miranpuri, G. S., & Resnick, D. K. (2010) · The Spine Journal · doi:10.1016/j.spinee.2010.08.015 · Cited by 26
Cannabinoids to treat spinal cord injury
Arévalo‐Martín, Á., Molina‐Holgado, E., & García‐Ovejero, D. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.03.008 · Cited by 27
Inhaled Cannabis Suppresses Chemotherapy-Induced Neuropathic Nociception by Decoupling the Raphe Nucleus: A Functional Imaging Study in Rats
Alkislar, I., Miller, A. R., Hohmann, A. G., Sadaka, A. H., Cai, X., Kulkarni, P., & Ferris, C. F. (2020) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2020.11.015 · Cited by 24
Positive Allosteric Modulators of Glycine Receptors and Their Potential Use in Pain Therapies
Gallagher, C. I., Ha, D. A., Harvey, R. J., & Vandenberg, R. J. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000583 · Cited by 26
Intrathecal administration of Resolvin D1 and E1 decreases hyperalgesia in mice with bone cancer pain: Involvement of endocannabinoid signaling
Khasabova, I. A., Golovko, M. Y., Golovko, S. A., Simone, D. A., & Khasabov, S. G. (2020) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2020.106479 · Cited by 25
Escalating morphine dosing in HIV-1 Tat transgenic mice with sustained Tat exposure reveals an allostatic shift in neuroinflammatory regulation accompanied by increased neuroprotective non-endocannabinoid lipid signaling molecules and amino acids
Hermes, D. J., Jacobs, I. R., Key, M. C., League, A. F., Yadav-Samudrala, B. J., Xu, C., McLane, V. D., Nass, S. R., Jiang, W., Meeker, R. B., et al. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01971-6 · Cited by 25
Rimonabant: more than an anti‐obesity drug?
Costa, B. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707139 · Cited by 22
The Role of Peripheral Cannabinoid Receptors Type 1 in Rats With Visceral Hypersensitivity Induced by Chronic Restraint Stress
Shen, L., Yang, X., Qian, W., & Hou, X. (2010) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm.2010.16.3.281 · Cited by 23
Allodynia Lowering Induced by Cannabinoids and Endocannabinoids (ALICE)
Luongo, L., Starowicz, K., Maione, S., & Marzo, V. D. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.02.019 · Cited by 24
Self-citation
In vitro and in vivo pharmacological characterization of ASP8477: A novel highly selective fatty acid amide hydrolase inhibitor
Watabiki, T., Tsuji, N., Kiso, T., 徹, 小., Narazaki, F., & Kakimoto, S. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.10.007 · Cited by 23
Optimized extraction of 2‐arachidonyl glycerol and anandamide from aortic tissue and plasma for quantification by LC‐MS/MS
Garst, C., Fulmer, M. L., Thewke, D. P., & Brown, S. D. (2015) · European Journal of Lipid Science and Technology · doi:10.1002/ejlt.201500115 · Cited by 22
Ultramicronized N-palmitoylethanolamine associated with analgesics: Effects against persistent pain
Nobili, S., Micheli, L., Lucarini, E., Toti, A., Ghelardini, C., & Mannelli, L. D. C. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108649 · Cited by 22
Exposure to Allergen Causes Changes in NTS Neural Activities after Intratracheal Capsaicin Application, in Endocannabinoid Levels and in the Glia Morphology of NTS
Spaziano, G., Luongo, L., Guida, F., Petrosino, S., Matteis, M., Palazzo, E., Sullo, N., de Novellis, V., Marzo, V. D., Rossi, F., et al. (2015) · BioMed Research International · doi:10.1155/2015/980983 · Cited by 21
Self-citation
The monoacylglycerol lipase inhibitor KML29 with gabapentin synergistically produces analgesia in mice
Crowe, M. S., Wilson, C. D., Leishman, E., Prather, P. L., Bradshaw, H. B., Banks, M. L., & Kinsey, S. G. (2017) · British Journal of Pharmacology · doi:10.1111/bph.14055 · Cited by 20
Inhibition of the regulator of G protein signalling RGS4 in the spinal cord decreases neuropathic hyperalgesia and restores cannabinoid CB1 receptor signalling
Bosier, B., Doyen, P. J., Brolet, A., Muccioli, G. G., Ahmed, E., Desmet, N., Hermans, E., & Deumens, R. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13324 · Cited by 20
Effects of centrally administered endocannabinoids and opioids on orofacial pain perception in rats
Zubrzycki, M., Janecka, A. E., Liebold, A., Ziegler, M., & Zubrzycka, M. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13970 · Cited by 21
The Endocannabinoid Reuptake Inhibitor WOBE437 Is Orally Bioavailable and Exerts Indirect Polypharmacological Effects via Different Endocannabinoid Receptors
Reynoso-Moreno, I., Chicca, A., Flores-Soto, M. E., Paredes, J. M. V., & Gertsch, J. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00180 · Cited by 20
Alterations in the Anandamide Metabolism in the Development of Neuropathic Pain
Małek, N., Kucharczyk, M. W., & Starowicz, K. (2014) · BioMed Research International · doi:10.1155/2014/686908 · Cited by 19
Repeated morphine treatment alters cannabinoid modulation of GABA ergic synaptic transmission within the rat periaqueductal grey
Wilson‐Poe, A. R., Lau, B. K., & Vaughan, C. W. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12809 · Cited by 18
The Potential Benefits of Palmitoylethanolamide in Palliation: A Qualitative Systematic Review
Davis, M. P., Behm, B., Mehta, Z. Y., & Fernandez, C. (2019) · American Journal of Hospice and Palliative Medicine® · doi:10.1177/1049909119850807 · Cited by 20
Natural Potent NAAA Inhibitor Atractylodin Counteracts LPS-Induced Microglial Activation
Yang, L., Ji, C., Li, Y., Hu, F., Zhang, F., Zhang, H., Li, L., Ren, J., Wang, Z., & Qiu, Y. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.577319 · Cited by 17
The endocannabinoid system as a therapeutic target in neuropathic pain: a review
Quintero, J.-M., Díaz, L. E., Galve‐Roperh, I., Bustos, R., Leon, M.-X., Beltran, S., & Dodd, S. (2024) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2024.2407824 · Cited by 18
Opioid and Endocannabinoid System in Orofacial Pain
Zubrzycki, M., Stasiołek, M., & Zubrzycka, M. (2019) · Physiological Research · doi:10.33549/physiolres.934159 · Cited by 19
Ultramicronized N-palmitoylethanolamine Contributes to Morphine Efficacy Against Neuropathic Pain: Implication of Mast Cells and Glia
Micheli, L., Lucarini, E., Nobili, S., Bartolucci, G., Pallecchi, M., Toti, A., Ferrara, V., Ciampi, C., Ghelardini, C., & Mannelli, L. D. C. (2022) · Current Neuropharmacology · doi:10.2174/1570159x21666221128091453 · Cited by 18
The endocannabinoid system in the brain undergoes long-lasting changes following neuropathic pain
Zhang, M., Wang, T., Meng, F., Jiang, M., Wu, S., & Xu, H. (2024) · iScience · doi:10.1016/j.isci.2024.111409 · Cited by 17
ASP8477, a fatty acid amide hydrolase inhibitor, exerts analgesic effects in rat models of neuropathic and dysfunctional pain
Kiso, T., Watabiki, T., & Sekizawa, T. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173194 · Cited by 16
Inhibition of 2-arachydonoylgycerol degradation attenuates orofacial neuropathic pain in trigeminal nerve-injured mice
Kamimura, R., Hossain, M. Z., Unno, S., Ando, H., Masuda, Y., TAKAHASHI, K., Otake, M., Saito, I., & Kitagawa, J. (2018) · Journal of Oral Science · doi:10.2334/josnusd.17-0005 · Cited by 16
Systemic and spinal administration of FAAH, MAGL inhibitors and dual FAAH/MAGL inhibitors produce antipruritic effect in mice
Yeşilyurt, Ö., Çayırlı, M., Sakın, Y. S., Seyrek, M., Akar, A., & Dogrul, A. B. (2016) · Archives of Dermatological Research · doi:10.1007/s00403-016-1649-4 · Cited by 15
Spinal glia-driven neuroinflammation as a therapeutic target for neuropathic pain: Rational development of novel analgesics
Zhang, Z., Niu, Z., & Dong, S. (2025) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2025.106404 · Cited by 18
Monoacylglycerol Lipase Protects the Presynaptic Cannabinoid 1 Receptor from Desensitization by Endocannabinoids after Persistent Inflammation
Bouchet, C. A., McPherson, K. B., Coutens, B., Janowsky, A. J., & Ingram, S. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.0037-23.2023 · Cited by 15
Median Nerve Stimulation as a Nonpharmacological Approach to Bypass Analgesic Tolerance to Morphine: A Proof-of-Concept Study in Mice
Lee, M. T., Chen, Y., Mackie, K., & Chiou, L. (2020) · Journal of Pain · doi:10.1016/j.jpain.2020.09.003 · Cited by 15
Effects of Cannabis and Cannabinoids in the Human Nervous System
Kalant, H. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-418679-8.00013-7 · Cited by 11
Involvement of leptin signaling in the development of cannabinoid CB2 receptor-dependent mirror image pain
Nozaki, C., Nent, E., Bilkei‐Gorzó, A., & Zimmer, A. (2018) · Scientific Reports · doi:10.1038/s41598-018-28507-6 · Cited by 12
Sex‐specific cannabinoid 1 receptors on GABAergic neurons in the ventrolateral periaqueductal gray mediate analgesia in mice
Jiang, Z., Wang, Q., Zhao, J., Wang, J., Li, Y., Dai, W., Zhang, X., Fang, Z., Hou, W., & Xiong, L. (2022) · The Journal of Comparative Neurology · doi:10.1002/cne.25334 · Cited by 12
Levels of neuropeptides nocistatin, nociceptin/orphanin FQ and their precursor protein in a rat neuropathic pain model
Joseph, T., Lee, T., Li, C., Chiang, S., Nishiuchi, Y., Kimura, T., & Tachibana, S. (2007) · Peptides · doi:10.1016/j.peptides.2007.05.009 · Cited by 12
Excessive alcohol intake produces persistent mechanical allodynia and dysregulates the endocannabinoid system in the lumbar dorsal root ganglia of genetically-selected Marchigian Sardinian alcohol-preferring rats
Borgonetti, V., Vozella, V., Ware, T., Cruz, B., Bullard, R., Cravatt, B. F., Galeotti, N., & Roberto, M. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107462 · Cited by 12
Role of the endocannabinoid system in a mouse model of Fragile X undergoing neuropathic pain
Ramírez‐López, A., Pastor, A., de la Torre, R., Porta, C. L., Ozaita, A., Cabañero, D., & Maldonado, R. J. (2021) · European Journal of Pain · doi:10.1002/ejp.1753 · Cited by 11
Role of Endocannabinoids in Neuron-Glial Crosstalk
Luongo, L., Palazzo, E., de Novellis, V., & Maione, S. (2010) · The Open Pain Journal · doi:10.2174/1876386301003010029 · Cited by 11
Self-citation
Palmitoylethanolamide and Related ALIAmides for Small Animal Health: State of the Art
Rocca, G. D., & Re, G. (2022) · Biomolecules · doi:10.3390/biom12091186 · Cited by 13
Targeting the Cannabinoid System to Produce Analgesia
Sagar, D. R., Jhaveri, M. D., & Chapman, V. (2009) · Current topics in behavioral neurosciences · doi:10.1007/978-3-540-88955-7_11 · Cited by 10
The potential anti-inflammatory and anti-nociceptive effects of rat hemopressin (PVNFKFLSH) in experimental arthritis
Camargo, L. L., Denadai‐Souza, A., Yshii, L., Lima, C., Teixeira, S. A., Cerqueira, A., Gewehr, M. C. F., Fernandes, E. S., Schenka, A. A., Muscará, M. N., et al. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173636 · Cited by 9
The Endocannabinoid System as a Therapeutic Target in Diabetic Peripheral Neuropathic Pain
Bagher, A. M. (2021) · Journal of Microscopy and Ultrastructure · doi:10.4103/jmau.jmau_97_20 · Cited by 9
Synthesis and evaluation of dual fatty acid amide hydrolase-monoacylglycerol lipase inhibition and antinociceptive activities of 4-methylsulfonylaniline-derived semicarbazones
Jaiswal, S., Akhilesh, A., Uniyal, A., Tiwari, V. K., & Ayyannan, S. R. (2022) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2022.116698 · Cited by 9
Upregulation of fatty acid amide hydrolase in the dorsal periaqueductal gray is associated with neuropathic pain and reduced heart rate in rats
Dean, C., Hillard, C. J., Seagard, J. L., Hopp, F. A., & Hogan, Q. H. (2017) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00481.2016 · Cited by 9
Dual Role of the Spinal Endocannabinoid System in Response to Noxious Stimuli: Antinociceptive Pathways and Neuropathic Pain Mechanisms
Saldaña, R., Carrascosa, A. J., Torregrosa, A. B., Navarrete, F., García‐Gutiérrez, M. S., & Manzanares, J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110692 · Cited by 8
Role of N-Acylethanolamines in the Neuroinflammation: Ultramicronized Palmitoylethanolamide in the Relief of Chronic Pain and Neurodegenerative DiseasesRole of N-Acylethanolamines in the Neuroinflammation: Ultramicronized Palmitoylethanolamide in the Relief of Chronic Pain and Neurodegenerative Diseases
Palazzo, E., Luongo, L., Guida, F., de Novellis, V., Boccella, S., Cristiano, C., Marabese, I., & Maione, S. (2019) · Neuropsychiatry · doi:10.4172/neuropsychiatry.1000549 · Cited by 8
Self-citation
A Glucuronic Acid-Palmitoylethanolamide Conjugate (GLUPEA) Is an Innovative Drug Delivery System and a Potential Bioregulator
Manzo, E., Moriello, A. S., Tinto, F., Verde, R., Allarà, M., PETROCELLIS, L. D., Pagano, E., Izzo, A. A., Marzo, V. D., & Petrosino, S. (2021) · Cells · doi:10.3390/cells10020450 · Cited by 8
Self-citation
A Role for the Cannabinoid 1 Receptor in Neuronal Differentiation of Adult Spinal Cord Progenitors in vitro is Revealed through Pharmacological Inhibition and Genetic Deletion
Sideris, A., Bekker, T., Chan, W. S., Montoya-Gacharna, J. V., Blanck, T. J. J., & Recio‐Pinto, E. (2012) · Frontiers in Neuroscience · doi:10.3389/fnins.2012.00004 · Cited by 8
N‐acylethanolamine‐hydrolysing acid amidase: A new potential target to treat paclitaxel‐induced neuropathy
Toma, W. B., Caillaud, M., Patel, N. H., Tran, T. H., Donvito, G., Roberts, J. L., Bağdaş, D., Jackson, A. B., Lichtman, A. H., Gewirtz, D. A., et al. (2021) · European Journal of Pain · doi:10.1002/ejp.1758 · Cited by 8
Système cannabinoïde et douleur : vers de nouveaux médicaments ?
Beltramo, M. (2009) · Journal de la Société de Biologie · doi:10.1051/jbio:2009002 · Cited by 8
Sex‐specific characteristics of cells expressing the cannabinoid 1 receptor in the dorsal horn of the lumbar spinal cord
Zhang, Y., Ke, J., Zhou, Y., Liu, X., Huang, T., & Wang, L. (2022) · The Journal of Comparative Neurology · doi:10.1002/cne.25342 · Cited by 7
Anandamide-Mediated Modulation of Nociceptive Transmission at the Spinal Cord Level
Spicarova, D., & Paleček, J. (2024) · Physiological Research · doi:10.33549/physiolres.935371 · Cited by 7
Endocannabinoid and N-acylethanolamide levels in rat brain and spinal cord following systemic dipyrone and paracetamol administration
Topuz, R. D., Gündüz, Ö., Karadağ, Ç. H., Dökmeci, D., & Ulugöl, A. (2019) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2019-0015 · Cited by 7
Disability-specific genes GRIN1, GRIN2 and CNR1 show injury-dependent protein expression in the lumbar spinal cord of CCI rats
Bembrick, A. L., Boorman, D. C., & Keay, K. A. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.134982 · Cited by 7
LC–MS Method for the Pharmacokinetic Evaluation of 2-Arachidonoyl Glycerol in Small Volume Plasma Samples
Paudel, K. S., Chen, J., & Stinchcomb, A. L. (2009) · Chromatographia · doi:10.1365/s10337-009-1413-4 · Cited by 7
Overlapping pathways of migraine and the endocannabinoid system: Potential therapeutic targets
Pietra, A. D., & Russo, A. F. (2026) · Neurotherapeutics · doi:10.1016/j.neurot.2026.e00833 · Cited by 6
Maladaptive changes in the homeostasis of AEA-TRPV1/CB1R induces pain-related hyperactivity of nociceptors after spinal cord injury
Hu, J., Fan, W., Xu, Y., Li, X., Zhang, H., Li, S., & Xue, L. (2025) · Cell & Bioscience · doi:10.1186/s13578-025-01345-6 · Cited by 6
URB937 Prevents the Development of Mechanical Allodynia in Male Rats with Trigeminal Neuralgia
Demartini, C., Greco, R., Zanaboni, A. M., Francavilla, M., Facchetti, S., & Tassorelli, C. (2023) · Pharmaceuticals · doi:10.3390/ph16111626 · Cited by 6
Decoding chronic pain: insights into the transition from acute to persistent pain
Wadhwa, K., Chauhan, P., Singh, G., Jha, S. K., Almutary, A. G., & Jha, N. K. (2025) · Open Biology · doi:10.1098/rsob.240234 · Cited by 5
Expression and Kinetics of Endogenous Cannabinoids in the Brain and Spinal Cord of a Spare Nerve Injury (SNI) Model of Neuropathic Pain
Kurosu, K., Islam, A., Sato, T., Kahyo, T., Banno, T., Sato, N., Matsuyama, Y., & Setou, M. (2022) · Cells · doi:10.3390/cells11244130 · Cited by 4
CB1cannabinoid receptor antagonism for treating inflammation and arthritis
Lambert, D. M. (2007) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.17.8.1027 · Cited by 5
Is inflammatory pulpal pain a risk factor for amnesia
Amirkhosravi, L., Raoof, M., Raoof, R., Abbasnejad, M., Esmaeili‐Mahani, S., Ramezani, M., nejad, H. E., Amanpour, S., & Haghani, J. (2014) · DOAJ (DOAJ: Directory of Open Access Journals) · doi:10.22067/veterinary.v6i2.33591 · Cited by 3
New Perspectives in Chronic and Neuropathic Pain in Older Population
Varrassi, G. (2015) · SOJ Anesthesiology & Pain Management · doi:10.15226/2374-684x/2/3/00126 · Cited by 3
Corticosterone stimulates synthesis of 2-arachidonoylglycerol via putative membrane-bound glucocorticoid receptors and inhibits GABA release via CB1 cannabinoid receptors in the ventrolateral periaqueductal gray
Coutens, B., Bouchet, C. A., Patti, L. C., McPherson, K. B., Boston, B. S., Jewett, D. C., & Ingram, S. (2025) · Molecular Pharmacology · doi:10.1016/j.molpha.2025.100058 · Cited by 2
Glucocorticoid–endocannabinoid crosstalk in the ventrolateral periaqueductal gray (vlPAG) promotes pain resolution
Coutens, B., Bouchet, C. A., Gvon, I., Patti, L. C., Gamboa, C. D. A., Jewett, D. C., Klawitter, J., Klawitter, J., Heinricher, M. M., & Ingram, S. (2026) · Neuropsychopharmacology · doi:10.1038/s41386-026-02529-5 · Cited by 2
Anandamide in the dorsal periaqueductal gray inhibits sensory input without a correlation to sympathoexcitation
Roberts, C. J., Hopp, F. A., Hogan, Q. H., & Dean, C. (2022) · Neurobiology of Pain · doi:10.1016/j.ynpai.2022.100104 · Cited by 2
Anti-nociceptive potential of an isatin-derived dual fatty acid amide hydrolase-monoacylglycerol lipase inhibitor
Jaiswal, S., Akhilesh, A., Tiwari, V., & Ayyannan, S. R. (2023) · Pharmacological Reports · doi:10.1007/s43440-023-00468-2 · Cited by 2
Anandamide and Other Acylethanolamides
Petrosino, S., & Marzo, V. D. (2009) · Springer eBooks · doi:10.1007/978-0-387-30378-9_5 · Cited by 2
Self-citation
Mast Cells and Glia as Targets for the Anandamide Congener Palmitoylethanolamide: an Anti-inflammatory and Neuroprotective Lipid Signaling Molecule
Skaper, S. D. (2017) · Springer eBooks · doi:10.1007/978-3-319-57371-7_12 · Cited by 2
Compensatory Activation of Cannabinoid CB2 Receptor Inhibition of GABA Release in the Rostral Ventromedial Medulla in Inflammatory Pain
Li, M., Suchland, K. L., & Ingram, S. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.1310-16.2017 · Cited by 2

Authors: Petrosino, S., Palazzo, E., de Novellis, V., Bisogno, T., Rossi, F., Maione, S., & Di Marzo, V.
Affiliations: Istituto di Chimica Biomolecolare (IT)
University of Campania "Luigi Vanvitelli" (IT)
ORCID: Petrosino, Stefania
Bisogno, Tiziana
Rossi, Francesco
Maione, Sabatino
Venue: Neuropharmacology
Publisher: Elsevier BV
Published: 2007-02
Volume: 52
Issue: 2
Pages: 415-422
ISSN: 0028-3908 (ISSN-L)
DOI: 10.1016/j.neuropharm.2006.08.011
OpenAlex: W2061301719
Cited by: 227
References: 46
Citations by year: 2026: 4 · 2025: 9 · 2024: 5 · 2023: 5 · 2022: 12 · 2021: 7 · 2020: 16 · 2019: 10 · 2018: 7 · 2017: 14 · 2016: 7 · 2015: 14 · 2014: 11 · 2013: 18 · 2012: 15
FWCI: 10.03
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Neuropharmacology (publishedVersion)
PubMed (publishedVersion)
Archivio Istituzionale della Ricerca - Università degli Studi della Campania "Luigi Vanvitelli" (submittedVersion)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Treatment
Keywords: endocannabinoids, neuropathic pain, anandamide, 2-arachidonoylglycerol, palmitoylethanolamide, chronic constriction injury, sciatic nerve, spinal cord, dorsal raphe nucleus, periaqueductal gray, rostral ventrolateral medulla, thermal hyperalgesia, mechanical allodynia, CB1 receptor, analgesia
MeSH terms: Analysis of Variance, Animals, Behavior, Animal, Disease Models, Animal, Male, Pain Measurement, Reaction Time, Sciatica, Mass Spectrometry, Spinal Cord, Time Factors, Rats, Wistar, Rats, Cannabinoid Receptor Modulators, Endocannabinoids

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Changes in spinal and supraspinal endocannabinoid levels in neuropathic rats

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks